Table 3.

Major Angiopathic Risk Factors in Relationship to Use of SMBGCharacteristic

Characteristic	Age
	≤ 65 years (n = 2099)			>65 years (n = 1169)
	SMBG	No SMBG	P value	SMBG	No SMBG	P value
	50.4% (n = 1058)	49.6% (n = 1041)		36.0% (n = 421)	64.0% (n = 748)
Sociodemographic
Mean agea	55.9 ± 5.7 (n = 1058)	57.3 ± 5.4 (n = 1041)	<0.001	71.9 ± 5.0 (n = 421)	73.4 ± 5.7 (n = 748)	<0.001
Femaleb	434 (41.0%)	465 (44.7%)	0.094	267 (63.4%)	493 (65.9%)	0.41
Smokerb	209 (19.8%)	195 (18.7%)	0.58	40 (9.5%)	53 (7.1%)	0.15
BMIa (kg/m2)	30.4 ± 5.0 (n = 817)	30.7 ± 5.2 (n = 785)	0.26	28.6 ± 4.5 (n = 307)	28.5 ± 4.8 (n = 551)	0.83
History of cardiovascular risk factors
Hypertensionb	619 (58.5%) (n = 1058)	683 (65.6%) (n = 1041)	0.001	285 (67.7%) (n = 421)	561 (75.0%) (n = 748)	0.008
Coronary heart diseasesb	156 (15.1%) (n = 1034)	164 (16.1%) (n = 1018)	0.54	149 (36.3%) (n = 410)	264 (36.1%) (n = 732)	0.95
Heart insufficiencyb	81 (7.8%) (n = 1036)	93 (9.2%) (n = 1013)	0.30	125 (30.7%) (n = 407)	202 (27.6%) (n = 732)	0.28
Peripheral arterial occlusionb	52 (5.0%) (n = 1035)	44 (4.3%) (n = 1018)	0.47	38 (9.3%) (n = 407)	55 (7.5%) (n = 732)	0.31
Myocardial infarctionb	33 (3.2%) (n = 1036)	32 (3.1%) (n = 1016)	1.00	27 (6.7%) (n = 406)	38 (5.2%) (n = 726)	0.35
Strokeb	27 (2.6%) (n = 1035)	17 (1.7%) (n = 1019)	0.17	17 (4.2%) (n = 407)	41 (5.6%) (n = 731)	0.33
Antihypertensive drugsb	409 (38.7%) (n = 1058)	536 (51.5%) (n = 1041)	<0.001	209 (49.6%) (n = 421)	452 (60.4%) (n = 748)	<0.001

^aData are means ± SD.

^bData are valid n (%).